Please assess the completion status of the following clinical trial:

Trial Title: Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Symptoms suspicious of bladder cancer (haematuria, ultrasonic and cystoscopy findings)~* Chronic spinal cord injury for a minimum of 3 years~* Informed Consent as documented by signature~Exclusion Criteria:~* Age \< 18 years~* History of bleeding disorder~* Bladder augmentation~* Acute, symptomatic urinary tract infection~* Pregnancy~* Urolithiasis~* Previous intravesical treatment (e.g. bladder irrigation, botulinum toxin injection) \< 2 weeks)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).